CeraVe, and Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system, have established the L’Oréal Dermatological Beauty/CeraVe Endowed Chair in Global Health Dermatology. 

At a recent celebration of changemakers in skin health held at MGH, Esther E. Freeman, MD, PhD, a highly recognized leader in the rapidly growing field of global health dermatology, was appointed the inaugural Chair of this initiative, which will improve access to dermatological care for underserved populations worldwide.

Dr. Freeman said,

“I am honored to be named the inaugural L’Oréal Dermatological Beauty/CeraVe Endowed Chair in Global Health Dermatology. This support will be instrumental in expanding our reach, training more healthcare workers, and improving skin health outcomes for vulnerable populations around the world. By investing in long-term mentorship, my goal is to help create a true ripple effect that will inspire sustainable care and empower the next generation of leaders in global health dermatology.”

The establishment of the inaugural Chair aims to address the growing global impact in skin health needs, underscoring CeraVe’s dedication to its “Care For All” social impact mission. 

CeraVe Global SVP, Medical Affairs & Communications Gene Colón, said,

“We at CeraVe have had the privilege of working alongside Dr. Esther Freeman over the past few years through her work at MGH and her philanthropic efforts, seeing firsthand her commitment to creating long-lasting change around the world. As a brand that believes everyone deserves access to skin health and resources, CeraVe sees this endowed Chair as an opportunity to work alongside changemakers like Dr. Freeman to improve access to essential dermatological care – a goal we’re committed to with CeraVe Care For All.”

Through this collaboration with CeraVe and MGH, Dr. Freeman, who currently serves as the Director of Global Health Dermatology at MGH and an Associate Professor of Dermatology at Harvard Medical School, will be provided with dedicated time and enhanced resources to address the growing needs in global health dermatology.

MGH has outlined the key outcomes of the Endowed Chair, including the flexibility to address urgent global needs and the provision of up to 20% protected time to focus on increasing access to dermatologic care in under-resourced settings worldwide through research, policy, training/mentoring, and advocacy. 

This investment reflects a joint commitment to expanding and sustaining global access to dermatological care. CeraVe and Mass General share a common vision of improving lives through accessible skincare and skin health.

The establishment of the L’Oréal Dermatological Beauty / CeraVe Endowed Chair in Global Health Dermatology signifies a lasting commitment to that vision.

Read Next

CeraVe & L’Oréal Groupe Win IFSCC Award

CeraVe Celebrates 20 Years with New Products